Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 9/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8946246 | 0.87 | CYP1A2 (0.42) | NQO2ALDH1A1 | |
| SCHEMBL8946276 | 0.86 | ACHE (0.40) | NQO2ACHE | |
| SCHEMBL8946339 | 0.83 | ESR1 (0.42) | NQO2KDM4EPOLBALDH1A1 | |
| SCHEMBL8946957 | 0.83 | NQO2 (0.39) | NQO2KDM4EATMALDH1A1 | |
| SCHEMBL9462823 | 0.83 | NQO2 (0.75) | NQO2MRGPRX4KDM4E | |
| SCHEMBL2905353 | 0.83 | NQO2 (0.56) | NQO2MRGPRX4KDM4EALDH1A1 | |
| SCHEMBL8946324 | 0.82 | NQO2 (0.61) | NQO2MRGPRX4KDM4EALDH1A1 | |
| SCHEMBL9463012 | 0.81 | NQO2 (0.64) | NQO2MRGPRX4KDM4EALDH1A1 | |
| SCHEMBL9462760 | 0.81 | NQO2 (0.64) | NQO2KDM4E | |
| SCHEMBL9462812 | 0.75 | NQO2 (0.64) | NQO2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5493027-A | ANTIEPILEPTIC AGENTS, NEUROGENATIVE DISEASES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1996-02-20 | — | — | US | disclosed |